BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 24009162)

  • 1. Randomized controlled trial of a behavioral intervention targeting symptoms and physical activity in multiple sclerosis.
    Pilutti LA; Dlugonski D; Sandroff BM; Klaren R; Motl RW
    Mult Scler; 2014 Apr; 20(5):594-601. PubMed ID: 24009162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive social cognitive treatment (can do treatment) with participation of support partners in persons with relapsing remitting multiple sclerosis: observation of improved self-efficacy, quality of life, anxiety and depression 1 year later.
    Jongen PJ; Heerings M; Ruimschotel R; Hussaarts A; Duyverman L; van der Zande A; Valkenburg-Vissers J; van Droffelaar M; Lemmens W; Donders R; Visser LH
    BMC Res Notes; 2016 Jul; 9():375. PubMed ID: 27473375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pragmatic intervention for increasing self-directed exercise behaviour and improving important health outcomes in people with multiple sclerosis: a randomised controlled trial.
    Carter A; Daley A; Humphreys L; Snowdon N; Woodroofe N; Petty J; Roalfe A; Tosh J; Sharrack B; Saxton JM
    Mult Scler; 2014 Jul; 20(8):1112-22. PubMed ID: 24421303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Internet intervention for increasing physical activity in persons with multiple sclerosis.
    Motl RW; Dlugonski D; Wójcicki TR; McAuley E; Mohr DC
    Mult Scler; 2011 Jan; 17(1):116-28. PubMed ID: 20921239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Internet-delivered lifestyle physical activity intervention improves body composition in multiple sclerosis: preliminary evidence from a randomized controlled trial.
    Pilutti LA; Dlugonski D; Sandroff BM; Klaren RE; Motl RW
    Arch Phys Med Rehabil; 2014 Jul; 95(7):1283-8. PubMed ID: 24699237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatigue, mood and quality of life improve in MS patients after progressive resistance training.
    Dalgas U; Stenager E; Jakobsen J; Petersen T; Hansen HJ; Knudsen C; Overgaard K; Ingemann-Hansen T
    Mult Scler; 2010 Apr; 16(4):480-90. PubMed ID: 20194584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal change in physical activity and its correlates in relapsing-remitting multiple sclerosis.
    Motl RW; McAuley E; Sandroff BM
    Phys Ther; 2013 Aug; 93(8):1037-48. PubMed ID: 23599354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive resistance training did not improve walking but can improve muscle performance, quality of life and fatigue in adults with multiple sclerosis: a randomized controlled trial.
    Dodd KJ; Taylor NF; Shields N; Prasad D; McDonald E; Gillon A
    Mult Scler; 2011 Nov; 17(11):1362-74. PubMed ID: 21677021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term impact of fampridine on motor and cognitive functions, mood and quality of life among multiple sclerosis patients.
    Pavsic K; Pelicon K; Ledinek AH; Sega S
    Clin Neurol Neurosurg; 2015 Dec; 139():35-40. PubMed ID: 26363365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Internet-delivered behavioral intervention to increase physical activity in persons with multiple sclerosis: sustainability and secondary outcomes.
    Dlugonski D; Motl RW; Mohr DC; Sandroff BM
    Psychol Health Med; 2012; 17(6):636-51. PubMed ID: 22313192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary approaches to treat MS-related fatigue: comparing the modified Paleolithic (Wahls Elimination) and low saturated fat (Swank) diets on perceived fatigue in persons with relapsing-remitting multiple sclerosis: study protocol for a randomized controlled trial.
    Wahls T; Scott MO; Alshare Z; Rubenstein L; Darling W; Carr L; Smith K; Chenard CA; LaRocca N; Snetselaar L
    Trials; 2018 Jun; 19(1):309. PubMed ID: 29866196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral fingolimod (FTY720) in relapsing multiple sclerosis: impact on health-related quality of life in a phase II study.
    Montalban X; Comi G; O'Connor P; Gold S; de Vera A; Eckert B; Kappos L
    Mult Scler; 2011 Nov; 17(11):1341-50. PubMed ID: 21727148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The psychosocial and cognitive impact of longstanding 'benign' multiple sclerosis.
    Sayao AL; Bueno AM; Devonshire V; Tremlett H;
    Mult Scler; 2011 Nov; 17(11):1375-83. PubMed ID: 21677023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of multiple sclerosis condition-specific measures to inform health policy decision-making: mapping from the MSWS-12 to the EQ-5D.
    Hawton A; Green C; Telford CJ; Wright DE; Zajicek JP
    Mult Scler; 2012 Jun; 18(6):853-61. PubMed ID: 22108867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spiroergometric and spirometric parameters in patients with multiple sclerosis: are there any links between these parameters and fatigue, depression, neurological impairment, disability, handicap and quality of life in multiple sclerosis?
    Rasova K; Brandejsky P; Havrdova E; Zalisova M; Rexova P
    Mult Scler; 2005 Apr; 11(2):213-21. PubMed ID: 15794397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency.
    Zamboni P; Galeotti R; Menegatti E; Malagoni AM; Gianesini S; Bartolomei I; Mascoli F; Salvi F
    J Vasc Surg; 2009 Dec; 50(6):1348-58.e1-3. PubMed ID: 19958985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical activity correlates with neurological impairment and disability in multiple sclerosis.
    Motl RW; Snook EM; Wynn DR; Vollmer T
    J Nerv Ment Dis; 2008 Jun; 196(6):492-5. PubMed ID: 18552627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial of an energy conservation course for persons with multiple sclerosis.
    Mathiowetz VG; Finlayson ML; Matuska KM; Chen HY; Luo P
    Mult Scler; 2005 Oct; 11(5):592-601. PubMed ID: 16193899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatigue in multiple sclerosis: association with disease-related, behavioural and psychosocial factors.
    Trojan DA; Arnold D; Collet JP; Shapiro S; Bar-Or A; Robinson A; Le Cruguel JP; Ducruet T; Narayanan S; Arcelin K; Wong AN; Tartaglia MC; Lapierre Y; Caramanos Z; Da Costa D
    Mult Scler; 2007 Sep; 13(8):985-95. PubMed ID: 17468448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resilience, self-efficacy, coping styles and depressive and anxiety symptoms in those newly diagnosed with multiple sclerosis.
    Tan-Kristanto S; Kiropoulos LA
    Psychol Health Med; 2015; 20(6):635-45. PubMed ID: 25588098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.